Male Infertility Market, Male Infertility Market, By Test (DNA Fragmentation Technique, Oxidative, Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer Assisted Semen Analysis, Sperm Penetration Assay and Others), By Technique (Assisted Reproductive Technology and Medication), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

The Male Infertility Market is divided into five regions: Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa. Over the course of the projection period, the Europe market is anticipated to have a notably high revenue share. Demand for male infertility is expected to rise in the area due to factors such as rising prevalence of male infertility rates, unhealthy diet and sedentary lifestyle, high disposable income, strong and well-developed fertility clinics, adoption of cutting-edge technologies, and high awareness of infertility.

Male infertility is on the rise in Europe, according to WWF (World Wide Fund For Nature). This is because of chemicals produced by humans that have decreased the number of sperm in males and caused them to burn out before laying an egg. Furthermore, the research indicates that almost 40% of young men in Denmark and one in five men in the UK have poor sperm counts and are unable to become fathers.

Furthermore, as male infertility rates in Britain climb, more and more ICSI (intracytoplasmic sperm injection) treatments are being conducted. In 2022, ICSI procedures accounted for around 52% of all fertility procedures performed in Europe, with over 122,000 ICSIs completed in 2004.

Because male infertility rates are on the rise, the Asia Pacific market is expected to increase at the fastest rate. Over the course of the forecast period, technological advancements in medical diagnostics are expected to fuel the expansion of the male infertility market in the area.